Inside the capsule, dose by dose
All 11 Ingredients, Checked Against The Research
Here is the full label exactly as disclosed on the official page, compared against the amounts typically used in human research for each ingredient.
The three biggest gaps
Berberine is the standout problem: its own research (Yin, Xing & Ye, 2008, PMID 18442638) used around 1,000 mg per day and showed real blood-sugar effects; ExiTide includes 15 mg, about one-sixtieth to one-hundredth of that. Glucomannan needs roughly 3,000 mg per day, taken before meals, to meet the dose behind the EU's own approved weight-management claim; ExiTide includes 50 mg. Curcumin studies for metabolic and anti-inflammatory effects typically use 500 mg or more; the 15 mg turmeric extract here contains roughly 14 mg of curcumin. None of these are trace amounts in the sense of being accidental, but none are close to a research-relevant dose either.
The two ingredients worth a closer look
Curcumin (from Turmeric) ~14 mg
Curcumin has real research behind it for inflammation and metabolic markers, but almost all of it uses 500 mg or more per day, often paired with piperine for absorption. At roughly 14 mg here, and with no mention of an absorption enhancer, this is present more as a nod to the ingredient than a functional dose.
Resveratrol Extract ~2.4 mg actual
The label lists 12 mg, but it is a 20% standardized extract, meaning the actual resveratrol content is closer to 2.4 mg. Human metabolic studies, such as Timmers et al. 2011, use 150 mg of resveratrol or more. The "standardized to 20%" detail is easy to skim past, and it matters here.
Ingredient photos are illustrative. The grape photo represents resveratrol generally; ExiTide's resveratrol is sourced from Polygonum cuspidatum (Japanese knotweed), a more common commercial source than grapes.
What the probiotics are doing
Bifidobacterium breve and Akkermansia muciniphila round out the formula at 1 billion CFU each. Akkermansia in particular is a genuinely interesting, forward-looking choice: it is the subject of real human metabolic research (Depommier et al., Nature Medicine, 2019), which found benefits at 10 billion CFU per day in overweight, insulin-resistant adults. ExiTide's 1 billion CFU is a tenth of that studied amount, still a real dose of a real strain, just on the low end.